1. Home
  2. LZB vs ABCL Comparison

LZB vs ABCL Comparison

Compare LZB & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$39.63

Market Cap

1.5B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$7.80

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZB
ABCL
Founded
1927
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
LZB
ABCL
Price
$39.63
$7.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$39.00
$8.40
AVG Volume (30 Days)
743.9K
7.1M
Earning Date
06-16-2026
05-11-2026
Dividend Yield
2.75%
N/A
EPS Growth
5.11
10.91
EPS
2.47
N/A
Revenue
$2,349,433,000.00
$75,128,000.00
Revenue This Year
$1.89
N/A
Revenue Next Year
$2.09
$21.85
P/E Ratio
$16.24
N/A
Revenue Growth
N/A
160.56
52 Week Low
$29.03
$2.75
52 Week High
$44.90
$8.42

Technical Indicators

Market Signals
Indicator
LZB
ABCL
Relative Strength Index (RSI) 55.66 72.41
Support Level $36.31 $3.32
Resistance Level $39.76 N/A
Average True Range (ATR) 1.73 0.54
MACD -0.01 0.24
Stochastic Oscillator 46.29 82.11

Price Performance

Historical Comparison
LZB
ABCL

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: